Vice President & Fellow, Oligonucleotide Chemistry

Eli Lilly and Company; Boston (MA); Presencial; USD 240.000 - 385.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

401(k)

Pension

Vacation benefits

Medical, dental, vision

Flexible benefits

Life insurance

Time off and leave

Well-being benefits

Descripción de la vacante

Eli Lilly and Company seeks a proven scientist to lead a team focused on oligonucleotide medicines. You will guide the design, screening, and optimization of siRNA, ASOs, and conjugates, while collaborating with therapeutic-area leaders to advance candidates into clinical evaluation.

The role emphasizes data-driven decision-making, inclusive leadership, and delivering transformative capabilities across Lilly’s RNA therapies portfolio.

Formación

• Ph.D. in chemistry or related field with >10 years of industry experience in oligonucleotide discovery and development.
• Proven leadership and ability to mentor scientists and develop talent.

Responsabilidades

• Hire, develop, and supervise Ph.D.- and associate-level scientists to support oligonucleotide medicines.
• Lead screening, design, and SAR optimization of oligonucleotide constructs (siRNA, ASOs, conjugates).
• Lead AI/ML integration into oligonucleotide strategy.
• Partner with legal to develop an IP strategy for novel oligonucleotide medicines.
• Present results clearly to teams and leadership.
• Drive advancement of technical capabilities for enterprise impact.
• Demonstrate learning agility and apply insights across discovery challenges.
• Maintain a strong focus on safety and collaborative culture.

Conocimientos

Team leadership

Data-driven decisions

Strategic thinking

Communication

Mentorship

Interdisciplinary collaboration

Educación

Ph.D. in chemistry

Descripción del empleo

Eli Lilly and Company seeks a proven scientist to lead a team focused on oligonucleotide medicines. You will guide the design, screening, and optimization of siRNA, ASOs, and conjugates, while collaborating with therapeutic-area leaders to advance candidates into clinical evaluation.

The role emphasizes data-driven decision-making, inclusive leadership, and delivering transformative capabilities across Lilly’s RNA therapies portfolio.